NF-kB kinase inhibitors (KRIBB/Jeil)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNF-kB kinase inhibitors (KRIBB/Jeil)
Drug Alias Name(-)-aptosimonJRK program (Jeil)nuclear factor kappa B kinase inhibitors (Korea Research Institute of Bioscience and Biotechnology/Jeil)JI-3292JI-4135
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKorean Research Institute of Bioscience and Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorean Research Institute of Bioscience and BiotechnologyJeil Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A